Ainos (AIMD) filed on Monday a preliminary prospectus for the resale from time to time of about 6.7 million shares by certain stockholders.

The prospectus covers 5.5 million shares issued in August as part of Ainos' patent license agreement with Taiwan Carbon Nano Technology, 500,000 shares issuable to privately held ASE Test by exercising warrants it received last May, and more than 700,000 shares issued to various directors, executives and other employees at Ainos through special stock awards vesting in recent weeks, according to the filing.

Ainos said it will not receive any proceeds from the prospective stock sales although it could receive up to $2.25 million in additional funding if ASE Test fully exercises its warrants at $4.50 per share.

Ainos shares climbed about 7% in recent trading.

Price: 0.48, Change: +0.03, Percent Change: +6.96